Annual Pharmacovigilance Report 2014

In 2014, the number of adverse drug reaction (ADR) reports in the Danish adverse reaction database came close to 100,000. The ADR reports go as far back as the late 1960s when the first national system for registration of adverse reactions was established.

Decline in reports from doctors

In 2014, the share of ADR reports from doctors was at the lowest level ever – a trend that we will try to reverse through campaigns and other initiatives. We also launched a new web service in 2014 for easier reporting of adverse reactions. Through a new initiative forming part of Action Plan III, we focus on strengthened training in ADR reporting as part of the medical education and the post-graduate speciality education.

Focus areas in 2014

Like the year before, we once again had focus on vaccines in 2014 – including the HPV vaccine, which is still in the media’s spotlight – and on ADR reports related to antiepileptics and labour-stimulating medicines for induction of labour.

Covered in the report

Covered in the Annual Pharmacovigilance Report 2014: The accumulated number of ADR reports, an overview of various safety issues we worked with in 2014; as well as various focus areas and the European pharmacovigilance collaboration.

Danish Health Authority's annual pharmacovigilance report 2014